Analyzing which pharmaceutical companies had the
highest sales in 2024 globally, we get the following picture:
Johnson & Johnson. - Leads the ranking with global
sales reaching $85.16 billion. This company has remained strong thanks to the
marketing of innovative drugs and high-quality products across various
therapeutic areas.
Roche. - One of the leaders with significant profits,
although the exact figures have not yet been detailed. However, their
investment in research and development in 2024 was approximately $10 billion.
Pfizer. - Holds a prominent position with sales of
$58.5 billion. Despite challenges like competition in the generics market,
Pfizer continues to be a leader in the development of innovative treatments.
AbbVie. - Ranks fourth with earnings of $54.3 billion.
Its focus on medications for chronic diseases and the marketing of innovative
products has maintained its position in this ranking.
Novartis. - Detailed figures for 2024 are not yet
available, but its consistent presence in the pharmaceutical market suggests it
remains a significant competitor. It is known for its Innovative Medicines
division and Sandoz division, which drive its revenues.
It's also worth noting that the market capitalization
of these companies does not always directly reflect their annual sales, but it
provides an idea of their value and market position. For example, Eli Lilly led
in market capitalization with approximately $738.8 billion in March 2024,
indicating its strong market presence.
An enthralling story of love, friendship and honor in the Olympic Games (2,600 years ago)
“Life debt” (Vicente Fisac, Amazon): https://a.co/d/hono34C
An enthralling story of love, friendship and honor in the Olympic Games (2,600 years ago)
“Life debt” (Vicente Fisac, Amazon): https://a.co/d/hono34C
No hay comentarios:
Publicar un comentario